SCHEMBL20176070

SCHEMBL20176070

CC(C#N)(Cc1ccccc1)O[Si](C)(C)CCl

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
LMNA P02545 1/20 0.35
CYP2D6 P10635 1/20 0.35
TRPA1 O75762 1/20 0.35
ATM Q13315 1/20 0.34
EGFR P00533 3/20 0.33
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP1B1 Q16678 1/20 0.33
SGMS2 Q8NHU3 1/20 0.32
PPARG P37231 1/20 0.32
PPARA Q07869 1/20 0.32
ALDH1A1 P00352 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20176092 0.85 DRD2 (0.35) EGFRSGMS2
SCHEMBL27669066 0.75 SLC6A2 (0.45) SLC6A2TAAR1LMNACYP2D6TRPA1
SCHEMBL20176041 0.75 CYP2D6 (0.35) TAAR1CYP2D6ATMALDH1A1CYP3A4
SCHEMBL27533554 0.72 SLC6A2 (0.42) SLC6A2TAAR1LMNACYP2D6TRPA1
SCHEMBL6724280 0.72 DRD2 (0.38) TAAR1CYP2D6ATMSGMS2
SCHEMBL20176083 0.72 DRD2 (0.35) ATMEGFRSGMS2ALDH1A1
SCHEMBL20176054 0.71 CYP2D6 (0.33) CYP2D6ATMCYP3A4
SCHEMBL20176072 0.71 DRD2 (0.35) EGFRCYP1A1CYP1A2CYP1B1SGMS2
SCHEMBL20176091 0.71 CTSS (0.33) CYP2D6
SCHEMBL20176046 0.70 ALDH1A1 (0.39) SLC6A2ATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10450331-B2 Functionalized cyanosilane and synthesis method and use thereof EAST CHINA NORMAL UNIVERSITY (CN) 2019-10-22 US disclosed
US-20180141964-A1 FUNCTIONALIZED CYANOSILANE AND SYNTHESIS METHOD AND USE THEREOF EAST CHINA NORMAL UNIVERSITY (CN) 2018-05-24 US disclosed
US-20180141964-A1 FUNCTIONALIZED CYANOSILANE AND SYNTHESIS METHOD AND USE THEREOF EAST CHINA NORMAL UNIVERSITY (CN) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141964-A1 FUNCTIONALIZED CYANOSILANE AND SYNTHESIS METHOD AND USE THEREOF NCLN, PNN, MB SLC6A2 237/4885TAAR1 805/4885LMNA 145/4885
US-10450331-B2 Functionalized cyanosilane and synthesis method and use thereof NCLN, PNN, MB SLC6A2 237/4885TAAR1 805/4885LMNA 145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.